Project description DEENESFRITPL Innovative sensors for detection of disease biomarkers Nanowire-based platforms using optical waveguided technology are capable of radically increased detection sensitivity for biomarkers such as proteins or pathogens. The technology requires cost-effective and reproducible production of high-quality nanowires. Aligned Bio in Sweden has developed a innnovative approach based on proprietary technologies, which allow the production of nanowires with controlled diameters to enhance the waveguiding properties of nanowire platforms. This unique technological combination results in an enhanced biomarker detection platform with 20 times greater sensitivity than currently available solutions. The goal of the EIC-funded NanoWi project is to bring the development of new sensors and the platform to final technology readiness level 9. Show the project objective Hide the project objective Objective Nanowire-based platforms are expected to radically impact disease diagnosis and precision medicine thanks to their high surface-area-to-footprint ratio and optical waveguiding properties. The challenge is to cost-effectively produce nanowires in a reproducible manner. At Aligned Bio, we have developed a new technology that enables, for the first time, mass- and cost-effective production of nanowire sensors. Our solution relies on three core patented technologies, which when combined, allow to produce low-cost, high-quality nanowires with controlled diameters to reproducibly enhance waveguiding properties of nanowire platforms. This unique combination of novel technologies results in enhanced biomarker detection platform devices with 20 times higher sensitivity than current solutions in the market and, crucially, at low price. To effectively carry out the tasks needed to reach TRL9, the EIC Accelerator project is crucial to bridging the critical risk-gap. Fields of science engineering and technologyelectrical engineering, electronic engineering, information engineeringelectronic engineeringsensorsmedical and health scienceshealth sciencespersonalized medicine Programme(s) HORIZON.3.1 - The European Innovation Council (EIC) Main Programme HORIZON.3.1.2 - The Accelerator Topic(s) HORIZON-EIC-2021-ACCELERATOROPEN-01 - EIC Accelerator Open 2021 Call for proposal HORIZON-EIC-2021-ACCELERATOROPEN-01 See other projects for this call Funding Scheme HORIZON-AG - HORIZON Action Grant Budget-Based Coordinator ALIGNEDBIO AB Net EU contribution € 2 315 943,88 Address Medicon village scheeletorget 1 22363 Lund Sweden See on map Region Södra Sverige Sydsverige Skåne län Activity type Private for-profit entities (excluding Higher or Secondary Education Establishments) Links Contact the organisation Opens in new window Participation in EU R&I programmes Opens in new window HORIZON collaboration network Opens in new window Other funding € 992 547,37
